Patient characteristics
| Characteristic | PDT (n = 14) | Non-PDT (n = 10) | P Value |
|---|---|---|---|
| Age (yr) | .98 | ||
| Median (range) | 61.5 (35–70) | 61.0 (36–72) | |
| Sex (No.) (%) | .92 | ||
| Male | 8 (57) | 6 (60) | |
| Female | 6 (43) | 4 (40) | |
| Preoperative Karnofsky Performance Status Scale score | .17 | ||
| Median (range) | 80 (30–100) | 70 (30–100) | |
| Tumor locations (No.) (%) | .67 | ||
| Frontal | 9 (64) | 5 (50) | |
| Temporal | 3 (21) | 4 (40) | |
| Parietal | 1 (7) | 1 (10) | |
| Basal ganglia | 1 (7) | 0 (0) | |
| Preoperative tumor volume (cm3) | .07 | ||
| Median (range) | 31.7 (2.2–140.0) | 70.3 (16.4–153.5) | |
| Extent of resection (No.) (%) | .91 | ||
| Gross-total | 10 (71) | 7 (70) | |
| Subtotal | 2 (14) | 1 (10) | |
| Partial | 2 (14) | 2 (20) | |
| Histopathology (No.) (%) | .14 | ||
| Glioblastoma | 11 (79) | 10 (10) | |
| Anaplastic astrocytoma | 1 (7) | 0 (0) | |
| Anaplastic oligodendroglioma | 2 (14) | 0 (0) | |
| Isocitrate dehydrogenase mutation status (No.) (%) | .50 | ||
| Wild-type | 11 (79) | 9 (90) | |
| Mutant | 3 (21) | 1 (10) | |
| MIB-1 index | .65 | ||
| Median (range) | 20 (10–80) | 20 (8–40) |